TechTalk: Automated measurement of BD-Tau and BD-p217-Tau in blood

Friday, October 16 at 15:00 BST | 16:00 CEST | 10:00 EDT | 7:00 PDT

Accurate measurement of brain-derived Tau (BD-Tau) and phosphorylated Tau (BD-p217 Tau) in blood is becoming increasingly important in Alzheimer’s disease and neurodegeneration research. However, established manual workflows can be time-consuming and may introduce variability, making it more difficult to achieve consistent, reproducible results.

In this SelectScience® TechTalk, join Oliver Schmidt, Tecan, to discover how two key neurodegeneration biomarkers, BD-Tau and BD-p217 Tau, can be applied on the TECAN Fluent® 780 instrument. He will explore their role in neurodegeneration research and demonstrate how automated workflows can support more efficient and consistent biomarker measurement.

You will gain practical insight into the application of BD-Tau and BD-p217 Tau assays, the advantages of moving away from manual procedures, and how automation can help streamline blood-based biomarker analysis for Alzheimer’s disease research.

Certificate of attendance
If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand TechTalk, you can request a certificate of attendance by emailing editor@selectscience.net.

TechTalk details

  • Cost: Free to attend
  • Location: Online
  • Duration: 20 minutes

Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available

Speakers

Oliver Schmidt
Oliver Schmidt
Speaker
Product Manager, TECAN, IBL International GmbH
See more

Who should attend?

This event is perfect for:
  • Neurodegeneration researchers
  • Neurologists

Brain-Derived Tau (BD-Tau) Luminescence Immunoassay

Tecan

The Brain-derived Tau (BD-Tau) LUM is a sensitive and accessible research-use only blood assay. Combining a specific antibody targeting brain-derived Tau with upfront immunoprecipitation, BD-Tau LUM offers researchers a powerful and accessible tool to investigate Alzheimer's disease pathology, progression, and biomarker dynamics in plasma.

(0)

p217 Tau Luminescence Immunoassay

Tecan

The p217 Tau LUM is a sensitive research tool that together with an upfront BD-Tau immunoprecipitation allows for the measurement of p217 BD-Tau in blood samples.

(0)

What will this webinar cover?

Join the TechTalk to get answers to these questions:

  • What roles do BD-Tau and BD-p217 Tau play in neurodegeneration research?
  • How can these biomarkers support Alzheimer’s disease research?
  • How are BD-Tau and BD-p217 Tau assays applied on the TECAN Fluent 780?
  • What advantages does automation offer over manual workflows?
  • How can automation improve the efficiency, consistency, and reproducibility of blood-based biomarker analysis?

Links

Tags

Register for free